<< Back to News

System Formulary Update
Tocilizumab-aazg (Tyenne)

Situation: Tocilizumab-aazg (Tyenne) 80 mg/4 mL; 200 mg/10 mL; and 400 mg/20 mL SDV injection were approved for addition to the UNC Health system at the System P&T meeting. 

Background: The following medication was reviewed: Tocilizumab-aazg (Tyenne) 80 mg/4 mL; 200 mg/10 mL; and 400 mg/20 mL SDV injection.

Assessment/ Recommendation: 

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Tocilizumab-aazg (Tyenne) 80 mg/4 mL; 200 mg/10 mL; and 400 mg/20 mL SDV injection

Note: Stock of this formulary product may vary at individual entities

Formulary/Epic Changes will Go-Live on Tuesday, December 24th